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Abstract:  In a previous study, we synthesized a series of peptides containing simple 
sequence repeats, (KW)n–NH2 (n = 2,3,4 and 5) and determined their antimicrobial and 
hemolytic activities, as well as their mechanism of antimicrobial action. However, (KW)5 
showed undesirable cytotoxicity against RBC cells. In order to identify the mechanisms 
behind the hemolytic and cytotoxic activities of (KW)5, we measured the ability of these 
peptides to induce aggregation of liposomes. In addition, their binding and permeation 
activities were assessed by Trp fluorescence, calcein leakage and circular dichrorism using 
artificial phospholipids that mimic eukaryotic liposomes, including phosphatidylcholine 
(PC), PC/sphingomyelin (SM) (2:1, w/w) and PC/cholesterol (CH) (2:1, w/w). Experiments 
confirmed that only (KW)5 induced aggregation of all liposomes; it formed much larger 
aggregates with PC:CH (2:1, w/w) than with PC or PC:SM (2:1, w/w). Longer peptide 
(KW)5, but not (KW)3 or (KW)4, strongly bound and partially inserted into PC:CH compared 
to PC or PC:SM (2:1, w/w). Calcein release experiments showed that (KW)5 induced calcein 
leakage from the eukaryotic membrane. Greater calcein leakage was induced by (KW)5 from 
PC:CH than from PC:SM (2:1, w/w) or PC, whereas (KW)4 did not induce calcein leakage 
from any of the liposomes. Circular dichroism measurements indicated that (KW)5 showed 
higher conformational transition compared to (KW)4 due to peptide-liposome interactions. 
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Taken together, our results suggest that (KW)5 reasonably mediates the aggregation and 
permeabilization of eukaryotic membranes, which could in turn explain why (KW)5 displays 
efficient hemolytic activity. 
Keywords: (KW)5; hemolytic peptide; eukaryotic membrane; phosphatidylcholine; 
cholesterol; sphingomyelin; aggregation 
 
1. Introduction 
Native and synthetic antimicrobial peptides (AMPs) exhibited a broad spectrum of activities against 
antibiotic resistant bacterial strains, including cancer cells [1]. Moreover, AMPs constitute key parts of 
the human and mammalian innate immune systems. In addition, AMPs are also involved in multiple 
defensive roles, such as regulating the inflammatory response and chemo-attracting cells of the adaptive 
immune system to wound/infection sites, binding and neutralizing lipopolysaccharides and promote 
re-epithelialization and wound closure in human skin against bacterial infections [2,3]. However, 
synthetic peptides utility is currently limited to topical application, because of their cytotoxicity against 
the eukaryotic cell membranes.  
Prokaryotic and eukaryotic cell membranes are mainly composed of phospholipids that differentiate 
their compositions [4]. It is well known that eukaryotic cell membranes are mainly composed of 
electrically neutral zwitterionic phospholipids, including phosphatidylcholine (PC), cholesterol (CH) 
and sphingomyelin (SM) [5]. Among these three phospholipids, the percentage of PC in the outer 
leaflets of eukaryotic membranes is higher than that of CH or SM [6]. Indeed, the outer leaflets of 
eukaryotic membranes are composed of lipids with no net charge. Accordingly, the small amount of 
negatively charged lipids is essentially located in the inner leaflet [7]. In contrast, bacterial membranes 
(e.g., in E. coli) lack CH, contain phosphatidylethanolamine as their most common zwitterionic lipid and 
are rich in anionic lipids, such as phosphatidylglycerol, and cardiolipin in their outer membranes [8]. 
This differentiation in phospholipid content between prokaryotic and eukaryotic membranes promotes 
selectivity by AMPs [9,10]. This selectivity of AMPs towards bacterial plasma membranes is very 
important for the design of novel antibiotic peptides with low cytotoxicity. However, many AMPs are 
non-selective between mammalian and microbial cells (e.g., pardaxin [11], melittin [12] and 
cathelicidins [13]). Therefore, various studies have attempted to determine the parameters that are 
responsible for AMP toxicity. It has been determined that high helicity, hydrophobicity and 
amphipathicity are correlated with an increase in eukaryotic cell toxicity [14]. Recent studies have also 
shown that aggregation/oligomeration of cationic antimicrobial peptides (cAMPs) is another parameter 
that is important for pore formation, regardless of the mechanism of cytotoxicity [15,16]. Accordingly, 
efforts have been undertaken to improve the selectivity of cAMPs, including sequence modification, to 
optimize their physiochemical parameters [17–20]. At present, short AMPs that minimize damage to 
host cells or tissue appear to be the most promising candidates for large-scale production [21,22]. In 
addition, the large size of AMPs is a hindrance due to high manufacturing costs. In response, selective 
short AMPs are currently being developed based on their amino acid composition, charge, 
hydrophobicity and length [21–25]. Specifically, lysine (K) or arginine (R)-tryptophan (W or Trp) or Int. J. Mol. Sci. 2013, 14  2192 
 
isoleucine (I)-phenylalanine (F) motifs have been designed for bacterial membrane selectivity [22,26]. 
However, KW, RIF or RW series peptides show increased hemolytic activity and hydrophobicity with 
higher chain length [22,26]. In a separate study using a de novo designed alpha helical HDP, high 
hydrophobicity was found to correlate with strong hemolytic activity [27]. However, there is insufficient 
data to support this claim. While hemolytic activity correlates with hydrophobicity values, there could 
be other factors affecting hemolytic activity. Therefore, we investigated the effects of peptide on model 
vesicles composed of a mixture of PC, CH and SM in order to determine their molecular mechanisms, 
since these three lipids are major constituents of most mammalian plasma membranes. It is also 
important to note that CH effectively suppressed the toxicity of AMPs against the eukaryotic membrane 
by preventing peptide induced eukaryotic membrane disruption via a barrel stave mechanism or other 
mechanism [28,29]. Also, a variety of biophysical approaches have reported mechanisms of membrane 
permeation/disruption activities of AMPs, including AMPs-induced liposome aggregation [30–33]. 
However, we believe this study will be useful in understanding the role of PC, SM and CH on hemolytic 
activity of AMPs. We found that only (KW)5 showed a strong interaction towards PC, PC:SM (2:1, w/w) 
and PC:CH (2:1, w/w) of the erythrocyte membrane. Moreover, (KW)5 induced aggregation/permeabilization 
of eukaryotic membranes.  
2. Results and Discussion  
Several studies have clearly shown that AMPs demonstrate activity against negatively charged 
bacterial membranes, whereas AMPs do not show strong activity towards zwitterionic eukaryotic 
membranes, suggesting non-activity against human cells [34–40]. Similarly, (KW)4 has shown strong 
selectivity against bacterial over eukaryotic membranes based on membrane interactions. However, 
when chain length exceeds the optimum number of 10 residues, (KW)5 shows interactions with both 
bacterial and eukaryotic membranes, resulting in antibacterial activity with cytoxicity towards 
eukaryotic cells [26]. In the present study, we investigated the interactions of (KW)n peptides with 
eukaryotic membranes to determine the increased hemolytic mechanism of (KW)5 compared to (KW)4. 
2.1. Liposomes Aggregation  
Liposome aggregation showed peptide-lipid interactions as previously reported [26,41]. We 
measured changes in liposome turbidity in order to determine the effects of (KW)n peptides on the sizes 
of PC, PC:SM (2:1, w/w) and PC:CH (2:1, w/w) vesicles (Figure 1). We found that (KW)2, (KW)3 and 
(KW)4 did not induce liposome aggregation towards PC, PC:SM (2:1, w/w) or PC:CH (2:1, w/w) 
vesicles, even at larger peptide concentrations. However, our results showed that (KW)5 was able to 
induce aggregation of liposomes. In addition, (KW)5 induced larger aggregation of PC:CH than either 
100% PC or PC:SM (2:1, w/w). This could be attributed to the membrane behavior of CH leading to 
enhanced peptide accumulation in the hydrophobic core of its bilayers, resulting in increased liposome 
aggregation. It was reported that (KW)5 is soluble and weakly self-aggregates in PBS, as determined 
from Trp fluorescence spectra, showing W-residues to be in a less polar environment (λmax = 342) [26]. 
Other studies have proposed that a peptide’s aggregation state in solution might affect eukaryotic 
membranes, resulting in cytotoxicity against RBCs [42,43]. This is in accordance with previous data on 
the hemolytic activity of (KW)5 peptide [26].  Int. J. Mol. Sci. 2013, 14  2193 
 
Figure 1. Large unilamellar vesicles (LUV) aggregation. Solutions containing various 
concentrations of peptide were added to a suspension of 400 μM PC (diamonds),   
PC:SM (2:1, w/w) (squares) and PC:CH (2:1, w/w) (triangles), after which aggregation was 
monitored based on changes in the absorbance of LUVs at 405 nm. (A) (KW)2; (B) (KW)3; 
(C) (KW)4; (D) (KW)5. 
 
(A) (B) 
 
(C) (D) 
2.2. Characterization of Trp Environment Using Fluorescence Spectroscopy 
To determine the mechanism behind (KW)5-induced aggregation of eukaryotic liposomes and 
whether or not it is mediated by interactions with the zwitterionic eukaryotic membrane, Trp 
fluorescence blue shift and Trp quenching experiments were carried out to compare the 
membrane-binding affinities of the peptides. Peptide binding to lipid bilayers was examined by 
recording the Trp fluorescence emission spectra in the presence of vesicles composed of zwitterionic 
PC, PC:SM (2:1, w/w) and PC:CH (2:1, w/w) (Figure 2). Blue shift assay indicated that (KW)3 and 
(KW)4 did not strongly interact with any of the liposomes. Peptides that interact with negatively charged 
bacterial membranes through electrostatic interactions initially experience enhanced accumulation on 
the bilayer surface [26]. On the other hand, bilayer disruption strongly depends on the properties of 
lipids, as well as peptide charge/hydrophobicity. Both (KW)3 and (KW)4 did not strongly bind with PC, 
PC:SM (2:1, w/w) or PC:CH (2:1, w/w) due to their zwitterionic character. Since PC membranes lack a 
net negative charge, cationic peptides cannot undergo electrostatic interactions with them. In contrast, 
(KW)5 showed strong interactions towards all liposomes. Among the three liposomes, larger blue shift 
of (KW)5 peptide suggests that its Trp side chain partitions more into PC:CH (7:3, w/w) lipid bilayers. 
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Figure 2. Blue shift in Trp fluorescence. Emission maxima from Trp in peptides in the 
presence of (A) PC; (B) PC:SM (2:1, w/w); and (C) PC:CH (2:1, w/w). (KW)3 (diamonds), 
(KW)4 (squares), (KW)5 (triangles). 
 
The accessibility of Trp residues into lipid bilayers can be determined by measuring the 
Stern-Volmer quenching constant for each peptide using soluble acrylamide as a quencher. In buffer, 
these peptides are almost completely accessible by acrylamide in aqueous solution [26]. The KSV of 
(KW)5 peptide was 1.7 M
−1, indicating that the Trp residues of (KW)5 were more protected in the 
presence of PC:CH (2:1, w/w) vesicles than in PC or PC:SM (2:1, w/w) vesicles (Table 1). This tendency 
was consistent with its potent aggregation activity towards eukaryotic liposomes. The lower Ksv values 
of vesicles composed of PC, PC:SM (2:1 w/w) and PC:CH (2:1 w/w) could be attributed to the 
hydrophobic effects and van der Waals forces that likely dominate the interactions between neutral 
lipids and the hydrophobic residues of (KW)5.  
Table 1. KSV parameters of peptides at 2 μM in PBS (pH 7.2) or in the presence of 200 μM 
PC, 200 μM PC:SM (2:1, w/w) and 200 μM PC:CH (2:1 w/w) LUVs. 
Peptides 
KSV (M
−1) 
a  
PC   PC:SM (2:1,w/w)   PC:CH (2:1 w/w)  
(KW)3   7.5   7.1   6.8  
(KW)4   7.2   6.8   6.2  
(KW)5   3.2   2.5   1.7  
Notes: 
a  KSV is the Stern-Volmer constant; KSV (M
−1) was determined from the Stern-Volmer Equation   
F0/F1 = 1+ KSV (Q), where Q is the concentration of quencher (acrylamide); Concentration of the quencher 
varied from 0.04 to 0.20 M.  
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2.3. Calcein Leakage  
Calcein leakage assay was performed to investigate interactions between AMPs and model   
liposomes [44]. We determined the ability of these peptides to cause leakage of entrapped calcein from 
PC, PC:SM (2:1 w/w) and PC:CH (2:1 w/w) vesicles, which mimic eukaryotic membranes. As shown in 
Figure 3, (KW)2 and (KW)3 did not release calcein from any of the three liposomes, whereas (KW)4 
showed slight calcein leakage at a higher concentration of 64 µm. Generally, significant leakage is not 
observed from LUVs enriched in PC, CH and SM by (KW)2, (KW)3 or (KW)4, which is consistent with 
their inability to induce aggregation/insertion in LUVs. In fact, Trp has a preference for the interfacial 
region of the lipid bilayer [45,46]. However, (KW)2, (KW)3 and (KW)4 did not deeply penetrate the 
hydrophobic region of the lipid bilayer, compared to (KW)5 (Table 1). This may suggest that interactions 
of cationic peptides, such as (KW)2, (KW)3 and (KW)4, with neutral zwitterionic lipids are weakened 
due to repulsion between the cationic peptides and positively charged head group of amino choline in 
PC, thereby inhibiting the hydrophobic interactions between peptides and eukaryotic membranes. 
However, (KW)5 showed eukaryotic membrane disruption ability due to two reasons. Firstly, (KW)5 
demonstrates weak aggregation in aqueous solution, which facilitates association of the peptide with 
liposomes by overcoming the repulsion between the peptide and lipid head group. Secondly, it has been 
described that increasing the number of Trp residues in AMPs naturally enhances membrane interactions 
and liposome leakage from PC or PC:CH; thus, (KW)5 is more able to interact with the interfacial region 
of the bilayer [47]. Previous studies have also described AMP activity on PC vesicle through interfacial 
activity, resulting in binding, insertion and perturbation [48]. Interfacial activity is also displayed by 
peptides having sufficient hydrophobicity [49]. It has been clearly suggested that (KW)5 peptides has 
higher hydrophobicity compared to (KW)3 and (KW)4. (KW)5 peptide associates with the hydrocarbon 
core of neutral bilayers and localizes near the aqueous phase in zwitterionic model membranes (Table 1). 
This increased local density of (KW)5, results in local disruption of lipid chains packing, leading to 
boundary disruption of lipid domains. The induced calcein release by (KW)5 was consistent with   
this notion.  
Figure 3. Percent leakage of calcein from (A) PC; (B) PC:SM (2:1, w/w); and (C) PC:CH  
(2:1, w/w) was measured for 25 min after the addition of various doses of peptide. 
 
(A) (B) (C) 
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2.4. Circular Dichroism (CD) 
Conformational changes of peptides were investigated by CD spectroscopy. Dramatic changes in the 
CD spectra occurred when (KW)5 was mixed with neutral lipids. In the presence of buffer, these peptides 
display random coil conformations [26]. When (KW)5 was added to PC, PC:SM (2:1, w/w) and PC:CH 
(2:1, w/w) liposomes, larger changes in CD spectra were observed, especially in PC:CH (2:1, w/w). 
(KW)5 shifted its minimum at 200 nm to 215 nm and gained a maximum at 195 nm, indicating   
that an extended beta-sheet structure was formed (Figure 4). Similar behaviors have been observed with 
AMPs, such as (RW)5 [22], suggesting that the high cost of partitioning peptide bonds into the 
membrane interface is a major driving force behind secondary structure formation in membrane   
environments [49–51]. Other studies also reported that peptides that are rich in aromatic residues bind 
well to the membrane interface [52]. In addition, previous information has shown that beta-sheet 
formation occurs upon induction of liposome aggregation by peptides [53]. Our CD measurement data 
also indicated that (KW)5 underwent a conformational transition from a random coil [26] to a beta-sheet 
structure. This was consistent with its ability to disrupt lipid bilayers and promote aggregation of 
liposomes. Other AMPs, such as (KW)2, (KW)3 and (KW)4, did not strongly bind to zwitterionic PC, 
PC:SM (2:1, w/w) or PC:CH (2:1, w/w) vesicles, which was consistent with their lack of hemolytic 
activity in erythrocytes [9,53,54]. In this case, no specific interaction with cholesterol was observed, 
which indicates low toxicity towards normal mammalian cells [55]. Indeed, certain melittin analogues 
fail to adopt appreciable secondary structures in the presence of a mammalian mimetic membrane, 
which could be associated with their failure to bind to and permeabilize hRBCs through a toroidal-pore 
mechanism resembling hemolytic activity [56]. 
Figure 4. CD spectra for (KW)4 and (KW)5 peptides in the presence of PC (dashed line), 
PC:SM (2:1, w/w) (dashed dotted line) and PC:CH (2:1, w/w) (dotted). (A) (KW)4 and  
(B) (KW)5. 
 
(A) (B) 
In this work, we confirmed that (KW)5 induces membrane aggregation (or interaction) and membrane 
perturbation of vesicles composed of PC:CH (2:1, w/w), PC/SM (2:1, w/w) and PC. We further 
demonstrated that SM, CH and PC are not specifically required for the action of (KW)5. Unlike (KW)5, it 
was reported that some eukaryotic membrane active peptides are selective to the lipid composition of the 
model eukaryotic membrane [57,58]. Although the results of this study support the idea that the Int. J. Mol. Sci. 2013, 14  2197 
 
mechanism of (KW)5 cytotoxicity involves membrane interactions/permeabilization along with 
liposome aggregation, further investigations are needed to explain how the liposome aggregation/fusion 
process is mediated. 
3. Experimental Section  
3.1. Materials 
Rink amide 4-methylbenzhydrylamine resin, fluoren-9-ylmethoxycarbonyl (Fmoc) amino acids and 
other reagents for peptide synthesis were purchased from Calibochem-Novabiochem (La Jolla, CA, 
USA). CH from porcine liver, egg yolk l-α-PC and SM were from Avanti Polar Lipids Co. (Alabaster, 
AL, USA). Calcein was obtained from Molecular Probes (Eugene, OR, USA). All other reagents were of 
analytical grade. Buffers were prepared using double distilled water (Millipore Co., Bedford, MA, USA). 
3.2. Peptide Synthesis and Purification  
Peptides were synthesized and purified as reported previously [26]. The purity of all peptides were 
found to be >95%. 
3.3. Preparation of Large Unilamellar Vesicles (LUVs) 
Large unilamellar vesicles (LUVs) were prepared by the freeze-thaw method [34,35]. Dry lipid films 
were resuspended in 1–2 mL of appropriate buffer by vortexing. LUVs were prepared by nine 
freeze-thaw cycles under liquid nitrogen and a water bath at 50 °C. After preparation of vesicles, 
suspensions were extruded 14 times through a 0.2 μM pore polycarbonate membrane. Lipid 
concentration was determined by standard phosphate assay [59].  
3.4. Liposome Aggregation  
Aggregation of lipid vesicles was monitored by visible absorbance measurements. The buffer used 
was PBS, pH 7.2. Peptides (5, 10, 20 and 40 μM) in PBS solutions were added to a suspension of 400 μM 
LUVs consisting of PC, PC:SM (2:1, w/w) and PC:CH (2:1, w/w). Increased absorbance indicated 
aggregation of liposomes. Absorbance was measured at 405 nm using a microplate Autoreader before 
and after the addition of peptides [60]. 
3.5. Trp Fluorescence and Acrylamide Quenching Assay  
Fluorescence emission spectra of Trp residue in peptides were monitored in the presence of PC, 
PC:SM (2:1, w/w) and PC:CH (2:1, w/w) LUVs. In these fluorescence studies, LUVs were used to 
minimize differential light scattering effects [61]. Trp fluorescence measurements were carried out using 
a spectrofluorometer. Each peptide was added to 1 ml of 200 μM liposomes, and the peptide:liposome 
mixture (a molar ratio of 1:100) was allowed to interact at 25 °C for 10 min. Fluorescence was measured 
at an excited wavelength of 280 nm an emission wavelength ranging from 300 to 400 nm.  Int. J. Mol. Sci. 2013, 14  2198 
 
Fluorescence quenching experiments were conducted using acrylamide as a quencher. The 
acrylamide concentration in the cuvette ranged from 0.04 to 0.20 M. The effect of acrylamide on the 
fluorescence of each peptide was analyzed using a Stern-Volmer Equation:  
F0/F = 1+ KSV (Q) (1)
where F 0 and F represent the fluorescence intensities in the absence and presence of acrylamide, 
respectively, KSV is the Stern-Volmer quenching constant and (Q) is the concentration of acrylamide. 
3.6. Calcein Leakage from Liposomes  
Calcein-entrapped LUVs composed of PC, PC:SM (2:1, w/w) and PC:CH (2:1, w/w) were prepared 
by vortexing the dried lipid in a dye buffer solution (70 mM calcein, PBS, pH 7.4). The suspension was 
freeze-thawed in liquid nitrogen for nine cycles, after which the calcein-entrapped vesicles were 
separated from free calcein by gel filtration chromatography on a Sephadex G-50 column. Entrapped 
LUVs in a suspension containing 100 μM lipids were then incubated with various concentrations of 
peptide (0.625–10 μΜ) for 25 min. The fluorescence of released calcein was assessed using a 
spectrofluorometer at an excitation wavelength of 480 nm and an emission wavelength of 520 nm. 
Complete (100%) release was achieved by the addition of 0.1% Triton X-100. Spontaneous leakage was 
determined to be negligible. All experiments were conducted at 25 °C, and the apparent percentage of 
released calcein was calculated according to the following Equation [62]:  
Release (%) = 100 × (F − Fo)/(Ft − Fo) (2)
where  F and Ft represent the fluorescence intensity before and after the addition of detergent, 
respectively, and Fo represents the fluorescence of intact vesicles. 
3.7. Circular Dichroism (CD) Spectroscopy  
The CD spectra were recorded on a Jasco 810 spectropolarimeter (Jasco, Tokyo, Japan) equipped 
with a temperature control unit using a 0.1-cm path-length quartz cell at 25 °C between 190 and 250 nm. 
The CD spectra were measured for peptide samples (50 μM) that were dissolved in PBS (pH 7.2) 
containing 1 mM PC, 1 mM PC:SM (2:1, w/w) vesicles or 1 mM PC:CH (2:1, w/w) vesicles. CD data 
represent the average value from three separate recordings, with four scans per sample. All CD spectra 
shown had corresponding peptide-free solvent baselines subtracted. The results are expressed in terms of 
molar residue CD. 
4. Conclusions  
Among (KW)n peptides, only (KW)5 induced permeation/aggregation of PC vesicles alone or in 
combination with CH or SM. Eukaryotic membrane aggregation induced by (KW)5 was dependent on 
both the presence of a more hydrophobic patch, as well as its ability to self-aggregate in aqueous solution 
compared to (KW)4. Therefore, (KW)5 is not a selective peptide against bacterial membranes   
compared to (KW)4. 
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